Thanks Giuseppe, Jerome, and Uwe. All of this makes sense to me. I will have to 
talk to our software and management people and decide what our best route is. 
Incidentally, we will also need FDA certification for this product. This is all 
a bit preliminary. The product is still in development. I’m in touch with the 
Qt office in Boston as well.

Cheers,
Colin

> On Oct 7, 2019, at 1:55 AM, Uwe Rathmann <uwe.rathm...@tigertal.de> wrote:
> 
>> On 10/6/19 12:03 PM, Giuseppe D'Angelo via Interest wrote:
>> 
>> Hey, I linked it two emails ago :-)
> 
> Ah yes, sorry.
> 
> My response was initially more explicit about FUD, before I decided, that it 
> is not worth the effort.
> 
> Uwe
> 
> 
> 
_______________________________________________
Interest mailing list
Interest@qt-project.org
https://lists.qt-project.org/listinfo/interest

Reply via email to